Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effects of Glucagon on Hepatic Metabolism
NCT05500586Phase 2Completed
- Start
- Oct 2022
- Primary completion
- Sep 2025
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of glucagon. Started Oct 2022; status: completed.
02
Drugs
glucagon
Beyond the preview
Go deeper on NCT05500586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05500586.